Alexander Capuco, Ivan Urits, Jamal Hasoon, Rebecca Chun, Brittany Gerald, Jason K Wang, Anh L Ngo, Thomas Simopoulos, Alan D Kaye, Matthew M Colontonio, Tomasina Q Parker-Actlis, Mitchell C Fuller, Omar Viswanath
No abstract text is available yet for this article.
March 27, 2023: Current Pain and Headache Reports
Andrea H Weinberger, Elizabeth K Seng
PURPOSE OF REVIEW: Tobacco use is associated with significant health consequences especially for people with medical conditions. Although lifestyle strategies (e.g., sleep, diet) are commonly recommended as part of migraine treatment, tobacco-related strategies (e.g., smoking cessation) are rarely included. This review is aimed at elucidating what is known about tobacco use and migraine and at identifying gaps in the research. RECENT FINDINGS: The prevalence of smoking is higher among people with migraine, and people with migraine believe that smoking makes migraine attacks worse...
March 11, 2023: Current Pain and Headache Reports
Maha Hameed, Sakshi Prasad, Esha Jain, Bekir Nihat Dogrul, Ahmad Al-Oleimat, Bidushi Pokhrel, Selia Chowdhury, Edzel Lorraine Co, Saloni Mitra, Jonathan Quinonez, Samir Ruxmohan, Joel Stein
PURPOSE OF REVIEW: Cannabis has been used since ancient times for medical and recreational research. This review article will document the validity of how medical cannabis can be utilized for chronic nonmalignant pain management. RECENT FINDINGS: Current cannabis research has shown that medical cannabis is indicated for symptom management for many conditions not limited to cancer, chronic pain, headaches, migraines, and psychological disorders (anxiety and post-traumatic stress disorder)...
March 10, 2023: Current Pain and Headache Reports
Aaron Kaplan, Safa Kaleem, Margaret Huynh
PURPOSE OF REVIEW: Aneurysmal subarachnoid hemorrhage carries high mortality and morbidity. Quality improvement (QI) efforts in the management of this disease process are growing as the field of neurocritical care matures. This review provides updates in QI in subarachnoid hemorrhage (SAH) and discusses gaps and future directions. RECENT FINDINGS: Literature published on the topic over the past 3 years were evaluated. An assessment of current QI practices pertaining to the acute care of SAH was conducted...
March 7, 2023: Current Pain and Headache Reports
Maya Kandah, Candy Wilson, Julie G Pilitsis
PURPOSE OF REVIEW: Patients diagnosed with neuropathic pain experience continuous or intermittent spontaneous pain throughout their lives. Pharmacological treatments often provide limited relief; therefore, a multidisciplinary approach should be utilized to manage neuropathic pain. This review examines the current literature on integrative health modalities (anti-inflammatory diets, functional movement, acupuncture, meditation, and transcutaneous therapy) for treating patients with neuropathic pain...
March 2, 2023: Current Pain and Headache Reports
David Walker, Niushen Zhang, Lauren R Natbony
PURPOSE OF REVIEW: The purpose of this review is to discuss the current evidence for Cognitive Behavioral Therapy for Insomnia (CBT-I) for patients with migraine and comorbid insomnia. In this article, we provide a narrative review of the literature on CBT-I and migraine, highlighting recent advances in research into this topic. Finally, we propose a way for clinicians to integrate CBT-I into clinical practice. RECENT FINDINGS: Multiple studies support CBT-I as a validated modality for the treatment of insomnia in migraine...
January 26, 2023: Current Pain and Headache Reports
Hao Tan, Erin A Yamamoto, Mohammed A Elkholy, Ahmed M Raslan
PURPOSE OF REVIEW: Deep brain stimulation (DBS) for chronic pain has been controversial. Despite the discouraging outcomes from multicenter clinical trial in the twentieth century, there is sustained interest in optimizing its use to improve patient outcomes. Here we provide a concise overview of DBS for chronic pain as a reference for clinicians. RECENT FINDINGS: Recently published data lends tentative support for DBS as a means of treating chronic pain. Still, high level-of-evidence data remain elusive...
January 2023: Current Pain and Headache Reports
Demario S Overstreet, Bethany D Pester, Jenna M Wilson, K Mikayla Flowers, Nora K Kline, Samantha M Meints
PURPOSE OF REVIEW: This review synthesizes recent findings related to the biopsychosocial processes that underlie racial disparities in chronic pain, while highlighting opportunities for interventions to reduce disparities in pain treatment among BIPOC. RECENT FINDINGS: Chronic pain is a prevalent and costly public health concern that disproportionately burdens Black, Indigenous, and people of color (BIPOC). This unequal burden arises from an interplay among biological, psychological, and social factors...
December 17, 2022: Current Pain and Headache Reports
Benjamin Gill, Kotomi Obayashi, Victoria B Soto, Michael E Schatman, Alaa Abd-Elsayed
PURPOSE OF REVIEW: Appropriate use of opioid analgesics is a key concern within the field of pain medicine. Several methods exist to discourage abuse and facilitate effective treatment regimens. Pill counting is often cited as one such method and frequently employed in varying fashions within clinical practice. However, to date, there is no published review of the evidence to support this practice. This was a comprehensive review of the available literature that was conducted with analysis of the efficacy and practical application of pill counting during treatment of chronic pain conditions...
December 2, 2022: Current Pain and Headache Reports
Denis Cherkalin, Sarang S Koushik, Simran Dua, Sadiq Rahman, Timothy Edmonds, Karina Gritsenko, Naum Shaparin
Spinal cord stimulator (SCS) is approved to treat various pain conditions and is commonly seen in the chronic pain patient population. Due to the nature of the device and its location, infections associated with SCS have a particularly high morbidity. According to post-market data and medical device reports, 87% of patients receiving SCS implants were given perioperative antibiotics as the implantable neurostimulator or receiver pocket serve as the most common sites of infection. The most common antibiotics for surgical prophylaxis given are first-generation cephalosporins (cefalexin, cefazolin) at the time of implantation...
December 2022: Current Pain and Headache Reports
Jade I Basem, Tiffany Lin, Neel D Mehta
PURPOSE OF REVIEW: Patients diagnosed with Ehlers-Danlos syndromes (EDS), and especially those with the hypermobility subtype, often experience a diverse range of acute and chronic pain conditions throughout their lifetime. These can present in a variety of different phenotypes and comorbidities, making it difficult to develop structured treatment protocols. This review seeks to summarize the current literature to address old and novel treatments for EDS. RECENT FINDINGS: Historically, medications and surgery have been used to treat patients with EDS but with low efficacy...
December 2022: Current Pain and Headache Reports
Kimberly N Garces, Alexandra N Cocores, Peter J Goadsby, Teshamae S Monteith
PURPOSE OF REVIEW: The aim of this review is to characterize headache as a vaccine adverse event (VAE) in clinical trials. RECENT FINDINGS: Of the recent phase III vaccine RCTs (non-COVID-19), 53 studies reported on headache (13 infectious agents). The median rate (interquartile range) of headache was 15.6% (IQR: 9.6-37.6%). Of these, 24.5% of the RCTs reported headache greater in the vaccine group compared to the placebo/control group. In the herpes zoster vaccination trials, headache was more common in all active groups: median rate 33...
December 2022: Current Pain and Headache Reports
Alaa Abd-Elsayed, Joshua M Martens, Kenneth J Fiala, Angelica Izuogu
PURPOSE OF REVIEW: Trigeminal neuralgia is a sudden, unilateral, stabbing pain in the distribution of one or more branches of the fifth cranial nerve, with an overall prevalence ranging between 0.03 and 0.3%. While conservative treatments may offer temporary relief, many patients experience chronic headaches associated with their neuralgia. Invasive treatments are available for patients with intractable neuralgia; however, they may cause permanent tissue damage and often do not provide relief...
December 2022: Current Pain and Headache Reports
Daniel G Rogers, Katie Santamaria, Elizabeth K Seng, Amy S Grinberg
PURPOSE OF REVIEW: The purpose of this review is to summarize advances in behavioral treatments for pain and headache disorders, as well as recent innovations in telemedicine for behavioral treatments. RECENT FINDINGS: Research for behavioral treatments continues to support their use as part of a multidisciplinary approach to comprehensive management for pain and headache conditions. Behavioral treatments incorporate both behavioral change and cognitive interventions and have been shown to improve outcomes beyond that of medical management alone...
November 23, 2022: Current Pain and Headache Reports
Nina Riggins, Lorenzo Paris
PURPOSE OF REVIEW: This study explores legal aspects of migraine in the workplace. While the high prevalence of migraine is well-documented, its effects on the livelihoods of those living with the disease are less understood. Because migraine symptoms are often invisible, discussions concerning migraine in the workplace can be challenging. What are the rights of persons with migraine in the workplace? Time off may provide a brief respite, but it is not a long-term solution. Claiming disability for migraine has challenges, including barriers to doing so and required paperwork...
November 18, 2022: Current Pain and Headache Reports
Sweta Sengupta, Timothy Collins
PURPOSE OF REVIEW: The perspective that pain corresponds to elevated blood pressure is overly simplistic. Our objective is to investigate and debunk misconceptions regarding the effect of pain on blood pressure. RECENT FINDINGS: While pain can increase blood pressure in the acute setting, prolonged pain and migraine's effect on blood pressure varies and can result in lower-than-expected blood pressure. Therefore, attributing pain as a sole source of elevation of blood pressure may lead to delays in diagnosing hypertension...
November 2022: Current Pain and Headache Reports
Yu-Kai Lin, Chia-Lin Tsai, Guan-Yu Lin, Chung-Hsing Chou, Fu-Chi Yang
PURPOSE OF REVIEW: Chronic migraine (CM) is a highly disabling primary headache disorder with a substantial impact on patients' quality of life. Episodic migraine (EM) and CM are dynamic states; CM usually evolves from EM alongside increased headache frequency, comorbidities, and medication overuse, supporting the notion that migraine is a spectrum disorder. This narrative review aims to summarize neuroimaging studies to better understand the pathophysiology of CM. RECENT FINDINGS: Positron emission tomography studies have revealed abnormal energy metabolism and metabolic changes in the dorsal rostral pons in individuals with CM, suggesting that this structure has a key role in the pathophysiology of migraine generation and chronification...
November 2022: Current Pain and Headache Reports
Nikita Chhabra, Marie F Grill, Rashmi B Halker Singh
PURPOSE OF REVIEW: Post-COVID headache may be unique in presentation and mechanism, often presenting as a new phenotype in patients with a history of a primary headache disorder or resulting in a new headache syndrome in those without history of headache. This review presents a description of the literature published focused on post-COVID headache. Additionally, we discuss potential mechanisms and considerations for treatment of post-COVID headache. RECENT FINDINGS: Headache is one of the most common symptoms of COVID...
November 2022: Current Pain and Headache Reports
Mila Pastrak, Nikola Vladicic, Jordan Sam, Bruce Vrooman, Frederick Ma, Ammar Mahmoud, James S Khan, Alaa Abd-Elsayed, Farhan Khandwalla, Scott McGilvray, Ognjen Visnjevac
PURPOSE OF REVIEW: The goal of this clinical review was to provide an update about the existing treatment options and associated evidence for various radiofrequency ablation techniques for sacroiliac joint pain. An electronic literature search on radiofrequency for the treatment of sacroiliac joint pain was conducted using PubMed, NCBI and Google Scholar. The following search keywords were used: radiofrequency ablation (cooled, pulsed, conventional, bipolar, intra-articular), sacroiliac joint and sacroiliac pain...
November 2022: Current Pain and Headache Reports
Jade I Basem, Paul Ryan Haffey
PURPOSE OF REVIEW: Centralized pain presents a complex pathology that many classic pharmacological agents for pain have not been able to sufficiently treat. To date, there are no clear guidelines for preferred treatment methods or comprehensive protocol that addresses confounding factors in this population. We sought to summarize the current field of knowledge around centrally mediated pain and to understand promising novel therapies. RECENT FINDINGS: Many treatments currently used address not only the centralized pain phenotypem but the impact of central sensitization and the common comorbidities that reside within this population...
November 2022: Current Pain and Headache Reports
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.